Equasens Stock

Equasens PEG

The PEG Ratio (Price/Earnings-to-Growth) of Equasens (EQS.PA) as of Aug 11, 2026 is 2.03.

PEG

2.03

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Equasens is 2026 2.03 . PEG Ratio (Price/Earnings-to-Growth) of Equasens was 2025 0.00 . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

PEG Ratio (Price/Earnings-to-Growth) of Equasens is 2.03 in 2026.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Equasens since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Equasens with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Equasens

All Key Metrics — Equasens